ECSP088971A - Ligandos 101 de los receptores nicotínicos de acetilcolina - Google Patents
Ligandos 101 de los receptores nicotínicos de acetilcolinaInfo
- Publication number
- ECSP088971A ECSP088971A EC2008008971A ECSP088971A ECSP088971A EC SP088971 A ECSP088971 A EC SP088971A EC 2008008971 A EC2008008971 A EC 2008008971A EC SP088971 A ECSP088971 A EC SP088971A EC SP088971 A ECSP088971 A EC SP088971A
- Authority
- EC
- Ecuador
- Prior art keywords
- acetilcoline
- ligandos
- nicotinic receptors
- methods
- diastomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Abstract
Ligandos de los receptores nicotínicos de acetilcolina de Fórmula I, donde X, n R1 y R2 son descritos en la descripción, diastómeros, enantiómeros, sales farmacéuticamente aceptables, métodos de producción, composiciones farmacéuticas que los contienen y métodos de uso de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74747606P | 2006-05-17 | 2006-05-17 | |
US82497506P | 2006-09-08 | 2006-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088971A true ECSP088971A (es) | 2009-01-30 |
Family
ID=38694158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008971A ECSP088971A (es) | 2006-05-17 | 2008-12-12 | Ligandos 101 de los receptores nicotínicos de acetilcolina |
Country Status (19)
Country | Link |
---|---|
US (2) | US7842803B2 (es) |
EP (1) | EP2019831B1 (es) |
JP (1) | JP2009537517A (es) |
KR (1) | KR20090007753A (es) |
AR (1) | AR060914A1 (es) |
AU (1) | AU2007250560B2 (es) |
BR (1) | BRPI0711941A2 (es) |
CA (1) | CA2652610A1 (es) |
CL (1) | CL2007001405A1 (es) |
EC (1) | ECSP088971A (es) |
ES (1) | ES2392997T3 (es) |
IL (1) | IL195019A0 (es) |
MX (1) | MX2008014436A (es) |
NO (1) | NO20084915L (es) |
RU (1) | RU2441007C2 (es) |
SA (1) | SA07280244B1 (es) |
TW (1) | TW200813067A (es) |
UY (1) | UY30349A1 (es) |
WO (1) | WO2007133155A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
AR049401A1 (es) | 2004-06-18 | 2006-07-26 | Novartis Ag | Aza-biciclononanos |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
WO2009066107A1 (en) * | 2007-11-21 | 2009-05-28 | Astrazeneca Ab | Use of a nicotinic receptor agonist |
TWI558398B (zh) | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α7活化劑之用途 |
CA2825142A1 (en) | 2011-01-27 | 2012-08-02 | Novartis Ag | Use of nicotinic acetylcholine receptor alpha 7 activators |
EA201391348A8 (ru) | 2011-03-18 | 2014-11-28 | Новартис Аг | КОМБИНАЦИИ АКТИВАТОРОВ АЛЬФА-7 НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА И АНТАГОНИСТОВ mGluR5, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ПРИМЕНЕНИЯ ПРИ ВЫЗВАННОЙ ДОПАМИНОМ ДИСКИНЕЗИИ, СВЯЗАННОЙ С БОЛЕЗНЬЮ ПАРКИНСОНА |
EA034964B1 (ru) | 2011-10-20 | 2020-04-13 | Новартис Аг | Биомаркеры, имеющие прогностическое значение в отношении ответа на лечение активатором альфа 7 никотиновых ацетилхолиновых рецепторов |
KR102043309B1 (ko) | 2012-12-11 | 2019-11-11 | 노파르티스 아게 | 알파 7 니코틴성 아세틸콜린 수용체 활성화제 치료에 대한 반응성의 예측 바이오마커 |
WO2014111751A1 (en) | 2013-01-15 | 2014-07-24 | Novartis Ag | Use of alpha 7 nicotinic receptor agonists for the treatment of narcolepsy |
EP2945633B1 (en) | 2013-01-15 | 2021-06-30 | Novartis AG | Use of alpha 7 nicotinic acetylcholine receptor agonists |
JP2016508159A (ja) | 2013-01-15 | 2016-03-17 | ノバルティス アーゲー | アルファ7ニコチン性アセチルコリン受容体アゴニストの使用 |
US11209254B2 (en) * | 2016-03-09 | 2021-12-28 | Msato, Llc | Pellet shaped marking round for air rifles and pistols |
HU231333B1 (hu) * | 2018-07-13 | 2023-01-28 | Richter Gedeon Nyrt | Spirokromán származékok |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
KR20040003021A (ko) * | 2001-06-01 | 2004-01-07 | 아스트라제네카 아베 | 치료에 유용한 니코틴성 아세틸콜린 수용체에 대한 신규리간드 |
CN1325499C (zh) * | 2002-04-18 | 2007-07-11 | 阿斯特拉曾尼卡有限公司 | 噻吩基化合物 |
WO2003087102A1 (en) * | 2002-04-18 | 2003-10-23 | Astrazeneca Ab | Furyl compounds |
AU2003224546B2 (en) * | 2002-04-18 | 2008-11-06 | Astrazeneca Ab | Heterocyclic compounds |
CA2538705A1 (en) * | 2003-09-25 | 2005-04-07 | Astrazeneca Ab | Ligands |
-
2007
- 2007-05-10 TW TW096116654A patent/TW200813067A/zh unknown
- 2007-05-14 AR ARP070102066A patent/AR060914A1/es not_active Application Discontinuation
- 2007-05-14 SA SA07280244A patent/SA07280244B1/ar unknown
- 2007-05-15 UY UY30349A patent/UY30349A1/es not_active Application Discontinuation
- 2007-05-16 CA CA002652610A patent/CA2652610A1/en not_active Abandoned
- 2007-05-16 RU RU2008143450/04A patent/RU2441007C2/ru not_active IP Right Cessation
- 2007-05-16 EP EP07748149A patent/EP2019831B1/en active Active
- 2007-05-16 KR KR1020087027857A patent/KR20090007753A/ko active IP Right Grant
- 2007-05-16 BR BRPI0711941-0A patent/BRPI0711941A2/pt not_active IP Right Cessation
- 2007-05-16 WO PCT/SE2007/000485 patent/WO2007133155A1/en active Application Filing
- 2007-05-16 CL CL2007001405A patent/CL2007001405A1/es unknown
- 2007-05-16 ES ES07748149T patent/ES2392997T3/es active Active
- 2007-05-16 JP JP2009510923A patent/JP2009537517A/ja active Pending
- 2007-05-16 MX MX2008014436A patent/MX2008014436A/es not_active Application Discontinuation
- 2007-05-16 AU AU2007250560A patent/AU2007250560B2/en not_active Ceased
- 2007-05-17 US US11/749,820 patent/US7842803B2/en active Active
-
2008
- 2008-10-30 IL IL195019A patent/IL195019A0/en unknown
- 2008-11-21 NO NO20084915A patent/NO20084915L/no not_active Application Discontinuation
- 2008-12-12 EC EC2008008971A patent/ECSP088971A/es unknown
-
2010
- 2010-11-05 US US12/940,449 patent/US20110136804A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CL2007001405A1 (es) | 2008-01-25 |
EP2019831A1 (en) | 2009-02-04 |
MX2008014436A (es) | 2008-11-27 |
US20080139600A1 (en) | 2008-06-12 |
IL195019A0 (en) | 2009-08-03 |
WO2007133155A1 (en) | 2007-11-22 |
RU2441007C2 (ru) | 2012-01-27 |
TW200813067A (en) | 2008-03-16 |
UY30349A1 (es) | 2008-01-02 |
KR20090007753A (ko) | 2009-01-20 |
AU2007250560A1 (en) | 2007-11-22 |
US7842803B2 (en) | 2010-11-30 |
SA07280244B1 (ar) | 2011-06-22 |
CA2652610A1 (en) | 2007-11-22 |
ES2392997T3 (es) | 2012-12-17 |
NO20084915L (no) | 2009-02-13 |
RU2008143450A (ru) | 2010-06-27 |
AU2007250560B2 (en) | 2011-06-23 |
EP2019831B1 (en) | 2012-09-12 |
AR060914A1 (es) | 2008-07-23 |
JP2009537517A (ja) | 2009-10-29 |
US20110136804A1 (en) | 2011-06-09 |
BRPI0711941A2 (pt) | 2011-12-13 |
EP2019831A4 (en) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088971A (es) | Ligandos 101 de los receptores nicotínicos de acetilcolina | |
UY31127A1 (es) | Ligandos de oxiadazol del receptor metabotropico para el glutamato y su utilizacion como potenciadores - 841 | |
HN2010001059A (es) | Nuevo titulo modificado: compuestos derivados de pirimidina, un proceso para la preparacion de los mismos, una composicion farmaceutica que los comprenden y combinaciones de dichos compuestos con otros agentes. | |
UY31870A (es) | Receptor metabotrópico de glutamato potenciadores 286 | |
CR9459A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
ATE483707T1 (de) | 2-cyclopropylthiazolderivate | |
ATE493386T1 (de) | Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate | |
UY29781A1 (es) | Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos | |
DK1599478T3 (da) | Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel | |
CR9587A (es) | Derivados de piridazina | |
ECSP067077A (es) | Derivados de pirrolopiridina y su uso como antagonistas de crth2 | |
NO20083630L (no) | Nye pyridinderivater | |
ATE524466T1 (de) | 3-azabicycloä3.3.0üoktanverbindungen | |
HK1120442A1 (en) | Novel opioid antagonists | |
NZ552137A (en) | New 4-benzylidene-piperidin derivatives | |
UY30316A1 (es) | Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
UY29896A1 (es) | Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
NO20073551L (no) | Nikotinacetylkolinreseptorligander | |
ATE409179T1 (de) | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten | |
ECSP099442A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
ECSP088829A (es) | Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1) | |
MX2010001574A (es) | Ligandos del receptor cannabinoide. | |
MX2010002584A (es) | Derivados de piperidina como agonistas de receptores muscarinicos. | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
MX2010008713A (es) | Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii. |